Hiroomi Nagata

Title: Hiroomi Nagata: Innovator in Pharmaceutical Chemistry

Introduction

Hiroomi Nagata is a distinguished inventor based in Osaka, Japan. He is known for his contributions to pharmaceutical chemistry, particularly in the development of novel drug substances. His innovative work has led to the creation of a unique crystal compound that holds significant potential in the medical field.

Latest Patents

Nagata holds a patent for a crystal of a pyrrolidine compound. This invention, specifically a crystal of 1-{2-[(3S,4R)-1-[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidine-3-carbonyl]-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid, is characterized by its quality that can be utilized as a drug substance. The invention also includes a crystal comprising an equimolar amount of the aforementioned compound and phosphoric acid.

Career Highlights

Nagata is currently employed at Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout his career, Nagata has collaborated with notable colleagues, including Naoko Ueda and Takahiro Yoshida. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hiroomi Nagata's contributions to the field of pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His patented work on pyrrolidine compounds showcases his commitment to advancing medical science.